Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
MMWR Morb Mortal Wkly Rep ; 64(16): 435-8, 2015 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-25928468

RESUMEN

On November 26, 2013, the CDC poxvirus laboratory was notified by the Boston Public Health Commission (BPHC) of an inadvertent inoculation of a recently vaccinated (ACAM2000 smallpox vaccine) laboratory worker with wild type vaccinia virus (VACV) Western Reserve. A joint investigation by CDC and BPHC confirmed orthopoxvirus infection in the worker, who had reported a needle stick in his thumb while inoculating a mouse with VACV. He experienced a non-tender, red rash on his arm, diagnosed at a local emergency department as cellulitis. He subsequently developed a necrotic lesion on his thumb, diagnosed as VACV infection. Three weeks after the injury, the thumb lesion was surgically debrided and at 2 months post-injury, the skin lesion had resolved. The investigation confirmed that the infection was the first reported VACV infection in the United States in a laboratory worker vaccinated according to the Advisory Committee on Immunization Practices (ACIP) recommendations. The incident prompted the academic institution to outline biosafety measures for working with biologic agents, such as biosafety training of laboratory personnel, vaccination (if appropriate), and steps in incident reporting. Though vaccination has been shown to be an effective measure in protecting personnel in the laboratory setting, this case report underscores the importance of proper safety measures and incident reporting.


Asunto(s)
Lesiones por Pinchazo de Aguja/complicaciones , Traumatismos Ocupacionales/diagnóstico , Traumatismos Ocupacionales/virología , Virus Vaccinia/aislamiento & purificación , Vaccinia/diagnóstico , Vaccinia/virología , Adulto , Animales , Cefazolina/administración & dosificación , Celulitis (Flemón)/diagnóstico , Celulitis (Flemón)/tratamiento farmacológico , Celulitis (Flemón)/etiología , Humanos , Infusiones Intravenosas , Personal de Laboratorio , Masculino , Massachusetts , Ratones , Orthopoxvirus/aislamiento & purificación , Infecciones por Poxviridae/diagnóstico , Infecciones por Poxviridae/virología , Vacuna contra Viruela/inmunología
2.
J Leukoc Biol ; 64(1): 108-113, 1998 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-29419900

RESUMEN

The mannose receptor is a macrophage surface receptor that mediates both endocytosis and phagocytosis. Previous work has demonstrated that the prototypical Th 2 cytokine, interleukin-4 (IL-4), increases both cell-surface receptor expression and mannose receptor-mediated endocytosis, whereas the prototypical Th 1 cytokine, interferon-γ (IFN-γ), decreases both surface expression and endocytosis. In many aspects of the immune response, Th 1 and Th 2 cytokines oppose each others' actions. We demonstrate that IL-4 and IFN-γ alone and together enhance mannose receptor-mediated phagocytosis, despite opposing effects on cell-surface mannose receptor expression and endocytosis. Thus these usually antagonistic cytokines cooperate in increasing mannose receptor phagocytic function. The cooperative effect of these cytokines is not observed for Fc receptor-mediated phagocytosis. The Th 2 cytokine IL-13 exerts similar effects to IL-4. Our results suggest that Th 1 and Th 2 cytokines may act in concert at sites of inflammation to enhance mannose receptor-mediated phagocytosis of microorganisms. J. Leukoc. Biol. 64: 108-113; 1998.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA